The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy
Primary Purpose
Seroma
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Microporous Polysaccharide Hemospheres (MPH)
Sponsored by
About this trial
This is an interventional prevention trial for Seroma
Eligibility Criteria
Inclusion Criteria:
- Age greater than or equal to 18 years
- Undergoing simple mastectomy with or without sentinel lymph nodes biopsy OR modified radical mastectomy for the treatment of breast cancer
Exclusion Criteria:
- Undergoing partial mastectomy
- Sentinel lymph node biopsy requiring conversion to axillary lymph node dissection
- Immediate reconstructive surgery
- Systemic anticoagulation
- Choosing not to participate in the study
Sites / Locations
- Memorial Health University Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention
Control
Arm Description
Application of Microporous Polysaccharide Hemospheres (MPH)
No MPH
Outcomes
Primary Outcome Measures
Total Drain Days
Time to Drain Removal
Total Drain Output
Total Drain Output in mL
Secondary Outcome Measures
Full Information
NCT ID
NCT03647930
First Posted
August 23, 2018
Last Updated
August 23, 2018
Sponsor
Memorial Health University Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT03647930
Brief Title
The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy
Official Title
The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy: A Prospective Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
May 15, 2012 (Actual)
Primary Completion Date
March 6, 2015 (Actual)
Study Completion Date
March 6, 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Memorial Health University Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Study aim was to evaluate topical MPH on the risk of post-mastectomy seroma formation as measured by total drain output and total drain days.
Detailed Description
Seroma formation is the most common complication after mastectomy and places patients at risk of associated morbidities. Microporous Polysaccharide Hemospheres (MPH) consists of hydrophilic, plant based, polysaccharide particles and is currently used as an absorbable hemostatic agent. An animal model evaluating MPH and seroma formation after mastectomy with axillary lymph node dissection showed a significant decrease in seroma volume. Study aim was to evaluate topical MPH on the risk of post-mastectomy seroma formation as measured by total drain output and total drain days.
Prospective randomized single-blinded clinical trial of patients undergoing mastectomy for the treatment of breast cancer. MPH was applied to the surgical site in the study group and no application in the control group.
Fifty patients were enrolled; eight were excluded due to missing data. Forty-two patients were evaluated, control (n=21) vs. MPH (n=21). No difference was identified between the two groups regarding demographics, tumor stage, total drain days, total drain output, number of clinic visits, or complication rates. On a subset analysis, body mass index (BMI) greater than 30 was identified as an independent risk factor for high drain output. Post hoc analyses of MPH controlling for BMI also revealed no statistical difference.
Unlike the data presented in an animal model, no difference was demonstrated in the duration and quantity of serosanguinous drainage related to the use of MPH in patients undergoing mastectomy for the treatment of breast cancer. BMI greater than 30 was identified as an independent risk factor for high drain output and this risk was not affected by MPH use.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Seroma
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Prospective randomized trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Application of Microporous Polysaccharide Hemospheres (MPH)
Arm Title
Control
Arm Type
No Intervention
Arm Description
No MPH
Intervention Type
Device
Intervention Name(s)
Microporous Polysaccharide Hemospheres (MPH)
Intervention Description
Microporous Polysaccharide Hemospheres (MPH)
Primary Outcome Measure Information:
Title
Total Drain Days
Description
Time to Drain Removal
Time Frame
23 Days
Title
Total Drain Output
Description
Total Drain Output in mL
Time Frame
23 Days
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age greater than or equal to 18 years
Undergoing simple mastectomy with or without sentinel lymph nodes biopsy OR modified radical mastectomy for the treatment of breast cancer
Exclusion Criteria:
Undergoing partial mastectomy
Sentinel lymph node biopsy requiring conversion to axillary lymph node dissection
Immediate reconstructive surgery
Systemic anticoagulation
Choosing not to participate in the study
Facility Information:
Facility Name
Memorial Health University Medical Center
City
Savannah
State/Province
Georgia
ZIP/Postal Code
31404
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
30674296
Citation
Suarez-Kelly LP, Pasley WH, Clayton EJ, Povoski SP, Carson WE, Rudolph R. Effect of topical microporous polysaccharide hemospheres on the duration and amount of fluid drainage following mastectomy: a prospective randomized clinical trial. BMC Cancer. 2019 Jan 23;19(1):99. doi: 10.1186/s12885-019-5293-1.
Results Reference
derived
Learn more about this trial
The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy
We'll reach out to this number within 24 hrs